How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

By Prof. OSSAMA RASSLAN Secretary General, Egyptian Society of Infection Control.
Infection Control Presented on behalf of the Infection Control Department, Gold Cost District Health Service January 2012.
SAFE-ITSM STANDARDS.
Disclosure: nothing to disclose
Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
The call The happy years The awakening Work to do Michelle Bushey, RN, BS, BSN, CIC Director Infection Prevention and Patient Safety.
Clostridium Difficile (C.diff): Fast Facts. What is Clostridium difficile (C. diff)? C. diff is a bacteria that lives in the intestinal tract of about.
Case discussion Michael Gardam University Health Network.
Controlling MRSA Michael Gardam Director, Infection Prevention and Control University Health Network, Toronto National MRSA Intervention Lead
Topical oropharyngeal vancomycin to control methicillin resistant Staphylococcus aureus lower airway infection in ventilated patients L. Silvestry et al.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
Outline Definition of isolation Principles of Isolation Isolation Policy Policy implementation Personnel Roles & Responsibilities Visitation.
Principles of Outbreak Management
Outbreak Scenario S. marcescens At a multi-disciplinary meeting on the surgical unit concerns are raised regarding a possible increase in.
Growing a New Culture: Patient Safety Nancy Brumley Gessling, MSN, CIC Infection Prevention Copper Basin Medical Center.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
1 Hospital Acquired Conditions. 2 Hospital Acquired Infections (HAI’s) Blood Stream Infections Ventilator Associated Pneumonia (VAP) Surgical Site Infections.
C. Difficile Prevention Collaborative: Learning and change in Massachusetts September 2012 Susanne Salem-Schatz, Sc.D. HealthCare Quality Initiatives
MRSA in Corrections Danae Bixler, MD, MPH
Infection Prevention & Control (IPAC) at RCHT Dr Tristan Clark Infectious Diseases physicin and joint DIPC.
1 Can the strict search-and-isolate strategy for controlling the spread of highly-resistant bacteria be mitigated? G Birgand a, I Lolom a, E Ruppe b, L.
Nosocomial Infections in Rural Hospitals William R. Barnett Robert Bolger MEDT 401 – Issues in Health Care April 29, 2004.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
APIC Chapter 13 Journal Club March 18, 2015
Rowena Thomas, RN Infection Control Nurse White Plains Hospital Greater NY York APIC Chapter 13 – Q&A Session November 19, 2014.
Brandon Merritt, MPH Regional Epidemiologist.  To discuss two recently identified CRKP outbreaks in separate Kanawha County long- term care facilities.
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Infection Control Clinical Pharmacy and Patient Safety
Outbreak of influenza A (H3N2) in a residence for mentally disabled persons in Ljubljana, Slovenia, 2013 Epidemiology and Public Health Valencia, Spain.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
Lou Ann Bruno, MD Chief of Infectious Diseases and Medical Director Of Infection Prevention NHSN Benchmark Med-Surg ICU:
1 Economic and medical adverse effects of a national policy to control the spread of highly-resistant micro-organisms. G Birgand a, M Schwarzinger b, A.
Time To Regain Control Management of Multi-Drug Resistant Organisms in Healthcare Settings
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
© Copyright, The Joint Commission 2015 National Patient Safety Goals.
RESULTS INTRODUCTION METHODS CONCLUSION  Since the early 90’s Enterococcus faecium resistant to Glycopeptides (GRE) have emerged in several French hospitals.
Eradication of a Burkholderia cepacia Outbreak in an Intensive Care Unit by a Bundled Environmental Hygiene Approach Elsa Santos-Cruz BSc, CIC September.
Nosocomial infection Hospital acquired infections.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
MRSA (Methacillin- Resistant Staph Aureus) Deborah Moore, MS, APRN, BC VT PHS Regional Administrator.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
Clinical Infectious Diseases 2012;55(6):764–70 Jan Vydra,1 Ryan M. Shanley,2 Ige George,1 Celalettin Ustun,1 Angela R. Smith,4 Daniel J. Weisdorf,1 and.
Is handwashing so effective? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand FRANCE ISICEM March 2009.
The Illinois Clostridium difficile Prevention Collaborative.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Nosocomial Antibiotic Resistant Organisms
Understanding Epidemiology
Infection Control and Preventions
Additional Precautions
Outbreak Investigations
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
CRE prevalence among patients with no prior history of carriage
Hospital acquired infections
2017 National Patient Safety Goals
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
MRSA Screen Before the Knife.
Disease Detective Team!
To screen or not to screen for VRE in immunocompromised patients?
MRSA=Methicillin resistant Staphylococcus aureus
“Bug of the month “ Pseudomonas aeruginosa (Gram negative bacilli)
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Department of Aging and Disability Services
Presentation transcript:

How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009

“The occurrence in a defined community or region, of cases of an illness with a frequency clearly in excess of normal expectancy”

VRE is an emergent pathogen responsible for outbreaks

Outbreak detection: Initial Call March 2004, a 70-yr old male admitted to MICU acute respiratory failure urine analysis positive for VRE faecium. January 2004 emergency repair of ruptured abdominal aneurism multiple successive units admission: surgical ICU, surgery, rehabilitation center

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

First step: verify the diagnosis Misdiagnosis Laboratory error

VRE from samples were isolated on Columbia agar (no enrichment broth) Biochemical identification and antibiotic testing were performed with Vitek 2 card. AB susceptibility was interpreted according to French national guidelines Glycopeptide resistance studied by determining MIC (E-test, AB biodisk) First step: verify the diagnosis

First: think prevention

Initial measures to limit VRE spread Reinforcement of contact precaution for VRE carrier care Strong recommendation for use of alcohol- based hand-rub (ABH) Wearing gloves and single use gown when entering the room Daily environmental cleaning Tracking contact patients for screening Briefings for HCWs with regular updates IC nurses verify the implementation of control measures

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

From January to March VRE faecium identified from clinical samples In 3 different wards In 2 of the 3 sites Confirm the outbreak

Over the 4 preceding years only 2 VRE per yr Despite –No recent change in reporting procedures –No recent change in diagnostic procedures Second step: Confirm the outbreak

VRE control committee Chief executive (hospital administrator) 1.Head physician of the infection control policy (CLIN) 2.Chief executive of the medical staff 3.Infection control physicians and nurses 4.Infectious diseases physicians 5.Hospital microbiologist 6.Director of nursing services 7.Representatives from the major clinical specialties and from the pharmacy.

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

Define, identify, and count cases Case definition colonized patient: VRE identified from surveillance cultures infected patient: VRE identified from clinical sample VRE carrier: patient either colonized or infected with VRE

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

Location 1 Location 2 Location 3

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

Factors associated with P <0.05 in multivariate analysis

1.Verify the diagnosis 2.Confirm the existence of an outbreak set up a control committee 3.Identify and count cases establish case definition 4.Orient data in terms of time, place and person 5.Formulate and test hypotheses 6.Conduct animal/environmental studies to identify source of the agent 7.Write a report What are the steps in an outbreak investigation? Implement control and prevention measures

Control measures focused on hand hygiene and reinforcement of contact precautions alcoholic-based solution for hand hygiene Outbreak detection antibiotic restriction 8.5 L/1000 days 17.8 L/1000 days single rooms, bed closures, admission restriction, regular meetings routine admission/weekly/discharge screening policy in wards where the outbreak was active decrease in the time for obtaining bacteriological swab results

Location 1 Location 2 Location 3 monthly rectal screening samples Colonized, N=163 Infected, N=57 urine culture, N=29, blood culture, N=9

The wards most affected by VRE Location 2 Location 3 Location 2Location 3

Vancomycin MIC > 256 mg/l Teicoplanin MIC ≥ 32 mg/l PCR analysis identified: VanA All of the strains expressed a high level of resistance to glycopeptide

Representative pulsed-field gel electrophoresis (PFGE) patterns of SmaI-restricted chromosomal DNA from VRE isolates

September Rectal swab screening in 1171 patients Colonization, N=2 (0.17%) ICU (N=1), LTCF (N=1) Large prevalence survey

outbreak committee with authority multidisciplinary collaboration multifaceted approach alcohol-based hand hygiene disinfection strong reinforcement of hygiene measures strict screening policy Conclusion

Acknowledgements Claire Aumeran Olivier Baud Bruno Coignard Olivier Lesens Ousmane Traoré Infection control nurses C-CLIN Sud-Est